outcome. 7 QOL is a multidimensional phenomenon consisting of physical, psychological, and social dimensions, 7 following BMT, an individual's QOL may be affected by As more women are treated with bone marrow transplantation (BMT) for breast cancer, there is growing difficulties in any or all of these areas. QOL following BMT has been examined in several surinterest in quality of life (QOL) following treatment. Although there have been some clinical studies of QOL vey studies. 7, 8 However, in some of these studies, QOL was assessed using methods of questionable reliability and valfollowing BMT, this area has received little systematic attention. In particular, it is unclear how QOL for idity, such as open-ended questionnaires, 9 patient interviews, 10 or non-validated QOL instruments developed by women treated with BMT for breast cancer differs from that which might be expected for 'healthy' women of the study authors. 11 In this introduction, only studies which employed standard, validated questionnaires to assess QOL about the same age. To address this issue, we compared QOL reported by women treated with autologous BMT following BMT are briefly reviewed. In a study conducted by Andrykowski and colleagues, 1 for breast cancer with that of a group of women of similar age with no history of cancer. In addition, we exam-QOL was assessed in individuals who were an average of 26 months post-BMT using the Functional Living Indexined the relationship of demographic factors, medical factors, and self-reported symptom prevalence, severity, Cancer (FLIC). 12 Based on mean FLIC scores, the QOL of the BMT survivors was similar to that of a normative samand distress to QOL in post-BMT patients. All participants completed the SF-36 Health Survey developed ple of cancer patients in active chemotherapy treatment. Poorer QOL in BMT survivors was associated with being from the Medical Outcomes Study (SF-36). Post-BMT patients also completed the ECOG Performance Status older (ie above age 30) at the time of BMT. The QOL of 135 individuals who were an average of 47 Rating Scale (PSR) and the Memorial Symptom Assessment Scale (MSAS). Results indicated that, compared months post-BMT was assessed by Baker and colleagues 3 using a measure of life satisfaction (Satisfaction with Life to the women with no cancer history, post-BMT patients reported significantly impaired physical functioning, Domains Scale; SLDS) 13 and a measure of emotional wellbeing (Profile of Mood States; POMS).
using a measure of life satisfaction (Satisfaction with Life to the women with no cancer history, post-BMT patients reported significantly impaired physical functioning, Domains Scale; SLDS) 13 and a measure of emotional wellbeing (Profile of Mood States; POMS).
14 Based on physical role functioning, general health, vitality, social functioning, and emotional role functioning. Impaired responses to the SLDS, the authors indicated that the BMT survivors reported an 'above average level of satisfaction' QOL following BMT was significantly associated with lower income, a longer time to engraftment, longer hoswith most areas of life but reported some dissatisfaction with physical strength and sexual relations. In addition, the pital stay, poor performance status, and greater symptom prevalence, severity, and distress. The problems BMT survivors in this study were found to have reported less tension, fatigue, and depression than the BMT suridentified in this study may be important targets for intervention when trying to improve QOL following vivors studied by Andrykowski.
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In a study of 125 individuals who had undergone BMT BMT. Keywords: quality of life; bone marrow transplantation an average of 10 years previously, Bush and colleagues 4 found that a majority of these BMT survivors (80%) rated their global QOL as good to excellent on the QLQ-C30, a quality of life questionnaire developed by the European During recent years there has been a growing interest in Organization for Research and Treatment of Cancer. 15 QOL following various cancer treatments, including Also, when these BMT survivors' mean QLQ-C30 scores BMT. [1] [2] [3] [4] [5] [6] Since information about QOL provides a broader were compared to norms for lung cancer patients prior to understanding of patients' experience with treatment treatment, 15 the BMT survivors reported significantly better beyond simple disease-free survival time, it is now conphysical functioning, role functioning, global QOL, and sidered an index of the 'effectiveness' of treatment and has social functioning. become an integral component in the assessment of medical
In a survey of 200 BMT recipients an average of 41 months after BMT, Andrykowski and colleagues 5 assessed QOL with a number of standardized questionnaires includ- Impact Profile (SIP). 16 Based on multiple regression analy-ses, QOL following BMT was found to be partly deterreviewed, we employed a standard, validated measure of QOL, the SF-36 Health Survey (SF-36).
18 mined by patients' education level; ie a lower education The aims of this study were to: (1) determine if the QOL level was predictive of more emotional distress and poorer reported by women who had undergone BMT for breast functioning following BMT. QOL was also partly detercancer was significantly more impaired than that of women mined by patients' age at the time of BMT; being younger of similar age with no history of cancer; and (2) identify at the time of BMT was predictive of better functioning the relationships of demographic factors, medical factors, after treatment.
and self-reported symptom prevalence, severity, and disThe above-mentioned studies were cross-sectional in tress to QOL in women who had completed BMT. design in that BMT recipients were assessed on only one occasion following BMT; there have been only a few prospective studies of QOL in BMT recipients. Syrala and colleagues 2 longitudinally assessed BMT recipients prior to hospital admission, 90 days post-BMT, and 1 year post-BMT using several measures including the SIP. 16 Patients' Patients and methods scores on the SIP revealed that compared to pre-BMT levels of functioning, patients reported a significant increase in dysfunction 90 days after BMT and a return to pre-transPatients plant functioning 1 year after BMT. In additional analyses, the authors used SIP scores one s.d. above normative values Participants for this study were drawn from the population to indicate impairment in global functioning. Using this criof women who had been treated at Moffitt Cancer Center teria, 65% of the sample reported that their global func-(MCC) with autologous BMT as treatment for breast cancer tioning was not impaired at 1 year post-BMT. However, between May 1990 and May 1995. As used in this paper, more than half of the sample (69%) reported impairment autologous BMT refers to high-dose chemotherapy folin their work activity, and almost half (46%) reported lowed by autologous stem cell rescue with peripheral blood impairment in recreation and pastimes. cells or bone marrow cells. To be eligible for the study, Andrykowski and colleagues 6 longitudinally assessed participants had to be a minimum of 3 months post-BMT QOL in BMT recipients prior to hospital admission and and have no evidence of disease according to the most approximately 1 year post-BMT. Participants completed the recent follow-up contact. They also had to: (1) be 18 years POMS, 14 FLIC, 12 and selected subscales from the SIP 16 and or older; (2) have no known untreated or unstable major from the Psychological Adjustment to Illness Scale medical conditions (eg diabetes); (3) have no known major (PAIS).
17 At 1 year post-treatment, the BMT recipients psychiatric or neurological disorders that would interfere reported more vigor but poorer sexual relationships than with completion of the measures; (4) be able to speak and they reported prior to treatment. BMT recipients' gender read English; and (5) have no history of treatment for other (ie being male) and age (ie being older) at the time of BMT types of cancer. were found to be predictive of a greater decline in QOL Of 50 post-BMT patients who met all eligibility criteria, from pre-BMT to post-BMT. three (5%) could not be reached, one (2%) refused to parSeveral methodological considerations limit the conticipate and two (4%) patients reported that they sent back clusions that can be drawn from the studies reviewed their questionnaire packets which were presumably lost in above. Most samples included male and female patients the mail. Thus, complete data was obtained from 44 (87%) with different disease sites or types of cancer. [1] [2] [3] [4] [5] [6] In patients for this study. One patient died shortly after addition, several studies combined recipients of autologous, returning her questionnaire from a breast cancer recurrence, allogeneic and/or syngeneic transplant. [3] [4] [5] [6] All the studies and thus was not free of disease at the time of her particiincluded BMT recipients with and without chronic GVHD.
pation. Because we intended to assess QOL in individuals Although all of these factors could influence QOL followwho were free of disease, this patient's data were elimining BMT, they were not systematically examined in most ated from the analyses (final sample ϭ 43). of the studies. [1] [2] [3] [4] In addition, previous research has relied Using peer nomination procedures (see below) a group primarily on published norms for comparison purposes. 1, 3, 4 of women with no history of cancer were also recruited. In It is unclear whether these normative groups share the same addition to having no history of any cancer, women in this demographic characteristics (eg age, gender) as the BMT group also had to: (1) be 18 years or older; (2) have no recipients to which they were being compared. known untreated or unstable major medical conditions; The current study was designed to improve on past stud-(3) have no known major psychiatric or neurological disies of QOL following BMT by focusing specifically on orders that would interfere with completion of the meas-QOL in women who had undergone autologous BMT for ures; and (4) be able to speak and read English. Of 53 breast cancer. In this way, gender, type of disease, and type women with no history of cancer identified as eligible partiof BMT were held relatively constant. To accrue an approcipants, two (4%) could not be reached, three (5%) refused priate group for comparison purposes, women of similar to participate, and five (9%) agreed to participate but did age with no history of cancer were also recruited and not return the questionnaire packet. Thus, complete data assessed. Comparison of QOL in these two groups of were obtained from 43 (81%) women with no cancer hiswomen was expected to provide a clearer understanding of tory. These women are hereafter referred to as the noncancer comparison subjects. the nature of QOL following BMT. Similar to the studies
Procedure and measures
report on the presence/absence of each symptom during the past week and, if present, the severity of the symptom on a three-point scale (1 ϭ slight; 3 ϭ severe) and the degree Patient self-report data for this study were obtained via a questionnaire administered through the mail. The specific of distress it produced on a four-point scale (0 ϭ not at all; 3 ϭ very much). Total scores can range from 0 to 26 procedures are described elsewhere. 19 In brief, post-BMT patients were contacted via telephone and, if they met eligion the prevalence subscale, 26-78 on the severity subscale, and 0-78 on the distress subscale. The MSAS was used in bility criteria, were recruited to the study. Those who agreed to participate were sent a packet of self-report questhe present study to evaluate the relationships of symptom prevalence, severity, and distress to QOL in post-BMT tionnaires and a stamped envelope to use in returning the packet. In addition, each post-BMT patient who agreed to patient. The MSAS has demonstrated good reliability (alpha coefficients Ͼ0.80) and validity with cancer participate was asked to nominate a female friend or relative within 5 years of her own age with no history of cancer patients.
22
(ie non-cancer comparison subject) to also participate in the study. The non-cancer comparison subjects were recruited Statistical methods to the study in a manner similar to that of the post-BMT patients.
Possible differences in demographic characteristics The self-report measures which were administered in this between the post-BMT patients and non-cancer comparison study are the SF-36 Health Survey, which was developed subjects were evaluated using analysis of variance from the Medical Outcomes Study (SF-36), 18 ,20 the Eastern (ANOVA) and 2 analyses. Possible differences between Collaborative Oncology Group Performance Status Rating the two groups on indices of QOL were evaluated by perScale (PSR), 21 and a modified version of the Memorial forming analyses of variance (ANOVA). In accordance Symptom Assessment Scale (MSAS). 22 Both groups of subwith the recommendation of the SF-36 scale authors, 18 2 jects completed the SF-36 and a demographic data form; analysis was used to compare differences between the post-BMT patients also completed the PSR and MSAS.
groups on the subscale measuring health transition. Finally, Information about post-BMT patients' cancer treatment (eg the relationship of demographic factors, medical factors, adjuvant treatments received prior to BMT, date of transperformance status, and symptom prevalence, severity, and plant, length of hospital stay for BMT) was obtained from distress to individual differences in QOL among post-BMT the computerized patient database maintained at MCC.
patients was examined by performing correlational and The SF-36 is a 36-item self-report measure designed to multiple regression analyses. assess perceived health and functioning. 18 The SF-36 contains the following eight subscales: (1) Physical functioning; (2) Role functioning-physical; (3) Bodily pain; (4) General health; (5) Vitality; (6) Social functioning; Results (7) Role functioning-emotional; and (8) Mental health. Scores on each of these eight subscales can range from 0-Demographic and medical variables 100. An additional one-item scale measures Reported Health Transition; respondents evaluate their current health Information about the demographic characteristics of the post-BMT patients and healthy comparison subjects is compared to 1 year ago using a five-point Likert scale (1 ϭ much better than 1 year ago, and 5 ϭ much worse than reported in Table 1 . The post-BMT patients ranged in age from 32-57 years (mean ϭ 44.4; s.d. ϭ 5.6). A majority 1 year ago). The SF-36 also yields two summary measures that were derived using factor analysis and are designed of these patients were white (98%), married (72%), and had attended college (86%). Approximately half (52%) reported to provide more global indices of functioning. 23 They are: (1) Physical health summary and (2) Mental health suma household income of at least $40 000 per annum, which is slightly above the average household income in the US. mary. Scores on these summary scales are expressed as Tscores (mean ϭ 50; s.d. ϭ 10). On all SF-36 scales, higher Thirty-seven percent were working outside the home fulltime, and an additional 16% were working part-time. The scores indicate a better health state. The validity of the SF-36 was evaluated using data on over 20 000 patients from non-cancer comparison subjects ranged in age from 32-56 years (mean ϭ 46.6; s.d. ϭ 5.7). A majority of these the Medical Outcome Study and the measure was found to be a valid measure of physical functioning and mental women were white (93%), married (70%), and had attended college (84%), reported an annual household income above health functioning.
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The PSR 21 is a one-item measure of performance status $40 000 (73%), and were employed outside the home on a full-time (73%) or part-time (8%) basis. There were no (ie overall physical status and ambulatory ability). The PSR can be completed by a patient as self-report or by a member significant (P Ͻ 0.05) differences between the BMT and comparison groups on age or any demographics with the of the medical staff observing the patient. In the present study, it was administered to post-BMT patients as a selfexception of working status: a significantly greater proportion of the non-cancer comparison subjects were report measure. The total score can range from 0-4. It was used in this study to examine the relationship between peremployed full or part-time (P Ͻ 0.001). Among the post-BMT patients, the average length of formance status and QOL in post-BMT patients.
The modified version of the MSAS 22 used in the present time since initial diagnosis of breast cancer was 3.3 years (s.d. ϭ 2.1; range 1 to 8 years). Prior to transplantation, study lists 26 symptoms commonly associated with current or past cancer treatment (eg nausea, chills). Respondents 96% of these patients received adjuvant chemotherapy, global indices of QOL (see Table 4 ). One demographic cancer diagnosis, size of the original tumor, cancer stage (I-IV) at the time of BMT, type of conditioning regimen, and current tamoxifen treatment were not significantly related to QOL. However, two indicators of overall treatment course were related to QOL following BMT: the num-67% received adjuvant radiotherapy, and 19% received ber of days from transplantation until neutrophil antihormonal therapy (tamoxifen). Approximately one-third engraftment and the length of hospital stay. In this sample, (35%) of post-BMT patients were receiving antihormonal there was an average of 18.4 (s.d. ϭ 7.9; range ϭ 9-42) therapy at the time of the study. At the time of BMT, 13 days to engraftment (defined as 3 consecutive days of (30%) of the patients had stage II breast cancer, 13 (30%) absolute neutrophil count greater than or equal to 500/ml) had stage III, and 17 (40%) had stage IV. With regard to and the average hospital stay was 38 (s.d. ϭ 19.8) days. A high-dose chemotherapy conditioning regimens, 53% of the longer time to engraftment and longer hospital stay were women in this sample received ifosfamide, carboplatin, and significantly related to poorer physical health after BMT. etoposide, 24 14% received mitoxanthrone and thiotepa, 25 These variables were not related to mental health. Poorer 16% received busulfan and cytoxan, 26 and 16% received performance status after BMT was significantly related to thiotepa, novantrone, and taxol. 27 The average length of poorer physical health and poorer mental health. Time since time since transplant was 20.3 months (s.d. ϭ 16.0; range BMT was not correlated with physical health or mental 3.5 to 62.5 months).
health. In addition, since some reports suggest that post-BMT patients experience a marked improvement in quality of life after the first year after completion of treatment, 8 an Differences on QOL measures ANOVA was conducted to compare QOL in patients less than 1 year post-BMT vs a year or more post-BMT. No Mean scores and standard deviations for the eight subscales and two summary scales of the SF-36 for the post-BMT significant differences were found between these patient subgroups in physical health or mental health. patients and non-cancer comparison subjects are presented Higher scores reflect better health state; Subscales scores range, 0-100. Summary scales are expressed as t-scores (mean ϭ 50; s.d. ϭ 10) a P р 0.05; b P р 0.01; c P р 0.001.
Table 3
Health transition ratings for post-BMT patients and non- With regard to self-reported symptoms, a greater number those reported by more than half the sample) and QOL. Fatigue (reported by 72% of post-BMT patients) was significantly related to poorer physical health (Ϫ0.51; P Ͻ 0.001) and poorer mental health (Ϫ0.44; P Ͻ 0.01). measures (see Table 5 ). Variables that were significantly B P Ͻ 0.001; multiple r ϭ 0.68; F (1, 41) ϭ 34.8; P Ͻ 0.001.
correlated with physical health (ie income, time to engraftment, hospital stay, performance status, and sympAlthough the post-BMT patients were experiencing more impairment, more of them reported that their health was tom prevalence, severity, and distress) were included in the pool of possible predictors of Physical Health Summary improved as compared to 1 year ago than did non-cancer comparison subjects. While it appears that this finding supscores. Results indicated that performance status was the single best predictor of physical health and that length of ports other studies that suggest women experience an improvement in emotional and physical health status over hospital stay accounted for additional significant variability in physical health. Variables which significantly correlated time following BMT, 6 limited conclusions can be drawn from this retrospective report in which women were asked with mental health (ie performance status and symptom prevalence, severity, and distress) were included in the pool to reflect on their health 1 year ago and rate their current health accordingly. Also, within the group of post-BMT of possible predictors of Mental Health Summary scores. Results indicated that symptom distress was the single best patients, time since BMT was not related to physical health or mental health functioning, and patients who were more predictor of mental health and that no other variable accounted for additional significant (P Ͻ 0.05) variability. than 1 year post-BMT did not report a better QOL than patients who were within the first year of treatment. These findings are inconsistent with other reports which suggest that the first year following BMT is difficult but that patients experience significant improvements in functioning Discussion after the first year.
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Within the group of post-BMT patients, poorer physical In this study, the QOL of women who had undergone BMT for breast cancer was compared to that of women of similar health was significantly related to lower income. A number of possible explanations can be offered for this finding. age with no cancer history. In addition, the relationship of demographic factors, medical factors, and self-reported Individuals with greater incomes may have more resources available to them (eg domestic help) to assist them in mansymptom prevalence, severity, and distress to QOL in post-BMT patients was assessed. The following discussion will aging daily activities, thus reducing their physical burden and stress. They may also have access to specialists (eg summarize the main findings and examine the clinical significance and implications of the results. massage therapists) who may help enhance their healing and sense of physical well-being. Finally, they may feel The post-BMT patients and non-cancer comparison subjects were demographically similar, with the exception of less pressured to return to work and can instead focus on their recovery. working status: significantly more of the non-cancer comparison subjects were employed outside the home. This difPoorer physical health following BMT was related to a number of medical factors including a more difficult treatference is likely due to the fact that 29% of the post-BMT patients who participated in this study were 6 months or ment course, ie a longer time to engraftment and a longer hospital stay. These variables were unrelated, however, to less post-treatment, and at MCC, patients are discouraged from returning to work for at least 6 months to reduce the mental health. These findings suggest that a patients' recovery course while in the hospital may be predictive of how risk of infection.
The post-BMT patients reported significantly more well they will function physically after BMT but not how well they function emotionally after BMT. More longitudiimpairment in physical functioning, physical role functioning, general health, vitality, social functioning, nal research is needed to identify the predictors of recovery following BMT for breast cancer. emotional role functioning, and global physical health than women of approximately the same age with no history of Poorer performance status was related to poorer physical health and poorer mental health. The finding that perforcancer. These findings suggest that women who undergo BMT for breast cancer experience more impairment in sevmance status was related to global physical health is not surprising since the two instruments used to measure these eral areas of QOL than what is 'normally' experienced by women of about the same age. These findings are inconsistvariables (PSR and 36-SF, respectively) assess essentially the same thing: perceived overall physical well-being and ent with those which suggest that patients experience a 'normal' QOL following BMT. 1, 3 However, since no other ability to function. Also, the relationship between performance status to physical health and mental health has been studies of QOL following BMT have used a comparison group of similar age with no history of cancer, comparing documented in other studies. 2 The results from this study may simply validate the use of the PSR as a brief selfour findings to those of other studies is limited. We compared these findings with those of another recent study in report measure of overall well-being in individuals who have completed BMT for breast cancer. which we found that women who had undergone radiotherapy for breast cancer (and were free of disease) experiWith regard to self-reported symptoms, poorer physical health and poorer mental health was related to a greater enced a QOL that was not significantly more impaired than that of women of similar age with no cancer history. 28 number of symptoms, greater symptom severity, and greater symptom-related distress. These findings support Comparison of these findings suggest that BMT, a more intensive treatment than radiotherapy, may explain the those from other research which suggest that the experience of more severe symptoms and symptom-related distress impairment in QOL evident in the women in this study. However, the extent to which the differences found in the may interfere with physical and emotional well-being.
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Two of the most frequently reported symptoms, fatigue and current study are attributable to pre-BMT treatments, ie adjuvant chemotherapy and radiotherapy, cannot be detersleep problems, were significantly related to QOL. This is consistent with findings from other reports which suggest mined. on QOL. 8, 19 8 Whedon M, Ferrell BR. Quality of life in adult bone marrow
The current study was limited by the fact that the sample transplant patients: beyond the first year. Semin Oncol Nurs
